Insider Transactions Reported by 17 Insiders of Kiromic Biopharma, Inc.

Location
Houston, TX

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Kiromic Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Internati Maurizio Chiriva CHIEF EXECUTIVE OFFICER, Director $5,097,488 09 Sep 2021
Scott Dahlbeck Chief of Staff $1,837,504 11 Aug 2022
Gianluca Rotino CHIEF STRAT & INNOV OFFICER, Director $1,036,001 22 Jun 2021
Pietro Bersani Chief Executive Officer, Director $517,357 23 Aug 2024
Michael Charles Ryan Chief Bioinformatics Research Officer $303,984 12 Jul 2021
Daniel Grant Clark Chief Financial Officer $232,186 11 Aug 2022
Michael Nagel Director $210,758 11 Jun 2024
Brian Hungerford Chief Financial Officer $142,658 19 Aug 2024
Pamela Misajon Director $121,091 12 Jun 2024
Ignacio Nunez Chief Operat. And Manuf. Offi. $65,509 22 Jun 2021
Michael Catlin Director $27,743 18 Mar 2024
Jerry A. Schneider Director $18,495 24 May 2021
Leonardo Mirandola Cso 03 May 2024
Americo Cicchetti Director 30 Jun 2022
Shannon Ralston 10%+ Owner 03 Jun 2024
Karen Reeves Director 30 Jun 2022
Francis X. Tirelli Director 30 Jun 2022

Recent Insider Transactions by Companies or Individuals for Kiromic Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.